跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 153,090 条关于
“Stargardt Disease Type 1”
全部
153,090
临床试验
114,320
药物
8,881
机构
1,539
资讯
28,350
9个月前
Belite Bio Raises $350 Million to Advance Retinal Disease Therapies Toward Commercialization
9个月前
Belite Bio's Tinlarebant Achieves 35.7% Reduction in Lesion Growth in First Successful Phase 3 Trial for Stargardt Disease
去年
Belite Bio's Tinlarebant Shows Progress in Stargardt Disease and Geographic Atrophy Trials
2年前
Belite Bio Doses First Patient in Phase 2/3 DRAGON II Trial of Tinlarebant for Stargardt Disease
去年
Belite Bio Presents Promising Phase II Data on Tinlarebant for Adolescent Stargardt Disease
去年
Belite Bio Completes Enrollment in Phase 3 PHOENIX Trial for Geographic Atrophy Treatment
8个月前
Ocugen's OCU410ST Gene Therapy Shows 54% Reduction in Stargardt Disease Progression in Phase 1 Trial
10个月前
Dry AMD Market Set for Significant Growth Through 2034 as Novel Therapies Advance in Clinical Development
2个月前
ASRS 2026: Durable Retina Therapies Take Center Stage as Gene Therapy, Implant and Oral Data Mature
去年
Gildeuretinol Receives FDA Fast Track and Rare Pediatric Disease Designations for Stargardt Disease
第 1 页,共 2835 页
上一页
下一页